The largest database of trusted experimental protocols

Ge lunar prodigy advance

Manufactured by GE Healthcare
Sourced in United States

The GE Lunar Prodigy Advance is a dual-energy X-ray absorptiometry (DXA) system designed for bone densitometry measurements. It is capable of measuring bone mineral density (BMD) and body composition parameters.

Automatically generated - may contain errors

22 protocols using ge lunar prodigy advance

1

Assessing Adiposity and Weight Satisfaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adiposity was assessed as body weight, BMI (body weight in kilograms (kg) divided by body height in meters squared (m)2), waist circumference measured in centimetres (cm) at the umbilical level with a measuring tape, and body fat and lean mass percentage measured by dual-energy X-ray (Lunar GE Prodigy Advance, GE Medical Systems, USA). Weight satisfaction (“Are you satisfied with your current weight?), ideal weight (“What is your ideal weight?) was assessed via questionnaire.
+ Open protocol
+ Expand
2

Anthropometric Measures of Adiposity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adiposity was defined by anthropometric measures: BMI (body weight in kilograms divided by height in meters squared (kg/m2)), waist circumference (measured at the umbilical level in centimetres by a measurement tape), and body composition (body fat and lean mass) measured by dual-energy X-ray absorptiometry (DEXA) (Lunar GE Prodigy Advance, GE Medical Systems).
+ Open protocol
+ Expand
3

Comprehensive Body Composition Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Weight and height were measured with light clothing and no shoes to the nearest 0.1 kilograms (kg) and 0.1 centimeters (cm) using the Jenix DS-102 height and weight scale (Dong Sahn Jenix, Seoul, Korea). Waist and hip circumference were measured to the nearest 0.1 cm with a Seca measurement tape at the level of the umbilicus and the greater trochanters, respectively. BMI (weight in kg divided by height in meters (m) squared) was defined as normal (<25 kg/m2), overweight (25–29.9 kg/m2), or obese (≥30 kg/m2). The 31 women and 2 men with underweight (BMI <18.5 kg/m2) were merged with the normal weight category.
Whole-body DXA scans (Lunar GE Prodigy Advance, GE Medical Systems) were performed according to the manufacturer guidelines, by trained technicians who inspected the postscan images and made relevant quality corrections to the regions of interest according to a standardized protocol. The DXA device was calibrated each morning with a phantom ahead of measurements. Total body fat in grams and percentage and android fat mass in grams were measured directly by DXA, and VATg and VATcm3 were subsequently computed by the validated CoreScan software (EnCore version 17.0). VAT% was calculated as 100 VATg divided by android fat mass (g), and subcutaneous fat mass was calculated as android fat mass (g) − VATg. VATindex was calculated as VAT kg/height (m)2.
+ Open protocol
+ Expand
4

HIV+ Individuals' VO2max Prediction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Participants completed 4, independently validated, N-EX questionnaires that were scored according to methods described previously by the creators: (1) Baecke Questionnaire,17 (link) (2) Modified George N-EX Questionnaire by Bradshaw et al,14 (link),15 (link) (3) Jackson N-EX Questionnaire,20 (link) and (4) International Physical Activity Questionnaire (IPAQ).18 (link),24 (link) Data from the questionnaires were used in an attempt to develop an accurate N-EX prediction equation of VO2max for HIV-infected individuals on HAART.
Maximal oxygen consumption was assessed with a Max IIa metabolic cart (AEI Technologies, Naperville, IL) using standard open-circuit spirometry techniques. Standardized measurements of respiratory exchange ratio, volume of oxygen consumed per minute (VO2), and volume of carbon dioxide produced per minute (VCO2) were calculated directly by the metabolic cart. The instrument was calibrated prior to each testing session. Heart rate (HR) was monitored by a Polar Sensor (Polar Electro, Lake Success, NY), compatible with the built-in interface of the metabolic system.
Body composition was assessed using dual-energy X-ray absorptiometry (DEXA) (GE Lunar Prodigy Advance, Encore 2004 software version 8.10.027, Waukesha, WI). Blood lactate levels were determined using a Lactate Plus Lactate Meter (Nova Biomedical Co., Waltham, MA).
+ Open protocol
+ Expand
5

Femoral Neck and Lumbar Spine Bone Density

Check if the same lab product or an alternative is used in the 5 most similar protocols
The main outcome of this research was BMD, obtained by Dual Energy X-ray Absorptiometry (DXA) (GE Lunar Prodigy Advance®), duly calibrated and using the GE Encore® software, version 14.10, configured to use the National Health and Nutrition Examination Survey (18 ) from the femoral neck and lumbar spine (L3 and L4 positions). All densitometry tests were performed by a trained radiology technician and the result reported by a single specialist physician to avoid interobserver variation. Data were extracted from medical records and those from exams performed up to 6 months after evaluation in the study were included. The women were classified into three groups as proposed by the World Health Organization (19 ): (1 (link)) Normal BMD (T-score ≥ −1.0 SD), (2 (link)) Osteopenia (T-score between −1.0 and −2.5 SD), and (3 (link)) Osteoporosis (T-score ≤ −2.5 SD).
+ Open protocol
+ Expand
6

Obesity Intervention: Comprehensive Metabolic Outcomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The primary outcome was 36‐week % change in BMI. At all study visits, body weight was assessed in light clothing using a calibrated scale. Height was assessed using a stadiometer. BMI was calculated as kg/m2 and BMI % changes were calculated. Secondary outcomes included 36‐week change in BMI, BMI Z‐score, waist circumference, waist‐to‐hip ratio and waist‐to‐height ratio. Waist and hip circumference were measured according to guidelines (http://www.cdc.gov/nchs/nhanes.htm). Additional measures of adiposity including total fat and lean body mass were obtained via dual energy x‐ray absorptiometry (DXA) at 0 and 36 weeks, adjusted for height, age and sex as covariates (GE Lunar Prodigy Advance; GE Lunar iDXA; and GE Hologic Discovery and Horizon). There were too few non‐white patients to adjust for race as a covariate.
The following metabolic outcomes were assessed after a 10‐12‐hour overnight fast: glucose, insulin, lipid panel, high sensitive C‐reactive protein and HbA1c. Samples were tested at a central laboratory (Northwest Lipid Research Laboratories, Seattle, WA, USA). Glucose tolerance was determined at 0, 18 and 36 weeks by a 2‐hour oral glucose tolerance test (75 g) with sample collection at 0, 30, 60, 90 and 120 minutes for measurement of glucose and insulin.
+ Open protocol
+ Expand
7

Measurement of Bone Mineral Density

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMD was measured by dual-energy X-ray absorptiometry (DXA; GE Lunar Prodigy Advance, Madison, WI, USA; software enCORE version 8.8) using an automatic scan mode. BMD was measured in the complete skeleton. The BMD values were expressed in grams per square centimeter. BMD spine analysis was performed in the lumbar segments 1–4 (L1–L4), and BMD hip analysis involved the whole femoral bone neck.
+ Open protocol
+ Expand
8

Bone Density Assessment in Participants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The main outcome of this study was the presence of osteopenia and osteoporosis assessed from BMD, obtained using DXA (GE Lunar Prodigy Advance®, GE Healthcare, Chicago, IL, USA), duly calibrated, and using the GE Encore® software, version 14.10, configured to use the National Health and Nutrition Examination Survey [21 ]. The BMD of the femoral neck and lumbar spine (L3 and L4 positions) was evaluated. All densitometry tests were performed by a trained radiology technician and the result reported by a single specialist physician to avoid interobserver variation. Data were extracted from medical records, and the results of exams performed up to six months before or after the study were included. Participants were classified into three groups: (1) Normal BMD (T-score ≥ −1.0 SD), (2) Osteopenia (T-score between −1.0 and −2.5 SD), and (3) Osteoporosis (T-score ≤ −2.5 SD) [22 ].
+ Open protocol
+ Expand
9

Body Fat Percentage Measurement by DEXA

Check if the same lab product or an alternative is used in the 5 most similar protocols
A dual-energy X-ray absorptiometry scan (Discovery W, Hologic, Bedford, Massachusetts, USA – GE Lunar Prodigy Advance GE Healthcare, Horton Norway) was performed to measure body fat percentage.
+ Open protocol
+ Expand
10

Measuring Pig Body Composition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pigs were weighed on arrival and three times during the adaptation period to calibrate the empirical component of model t before the experimental period. Animal performance was evaluated as the average daily feed intake (ADFI), average daily weight gain (ADG), feed-to-gain ratio (G:F), SID Lys intake, SID Thr intake, Lys and Thr efficiency of utilization for PD, PD, the proportion of protein in ADG (PD/ADG, %), and lipid deposition (g/d). Total body fat and lean content were measured by dual X-ray absorptiometry on days 0 and 21 with a densitometer device (GE Lunar Prodigy Advance, Madison, WI, USA). Pigs were scanned in the prone position using the total body scanning mode (Lunar enCORE Software version 8.10.027; Lunar Prodigy Advance, Madison, WI, USA). During the scans, anesthesia was induced with sevoflurane (7%) and maintained with isoflurane (5%).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!